Novel Therapeutic Approaches to the Treatment of Parkinsons Disease: An Overview
243,52 €
Targeting α-Synuclein as a Parkinson's Disease Therapeutic. - Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors. Subtitle An Overview and Update. Format Paperback. Table of Contents. Place of Publication Cham.
Jetzt bei Ebay: